These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 21080338

  • 41. Effect of ginsenoside Rh-2 via activation of caspase-3 and Bcl-2-insensitive pathway in ovarian cancer cells.
    Kim JH, Choi JS.
    Physiol Res; 2016 Dec 13; 65(6):1031-1037. PubMed ID: 27959575
    [Abstract] [Full Text] [Related]

  • 42. Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
    Musende AG, Eberding A, Wood C, Adomat H, Fazli L, Hurtado-Coll A, Jia W, Bally MB, Guns ET.
    Cancer Chemother Pharmacol; 2009 Nov 13; 64(6):1085-95. PubMed ID: 19301006
    [Abstract] [Full Text] [Related]

  • 43. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.
    Nakata H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, Kudoh K, Nagata I, Shinomiya N.
    Jpn J Cancer Res; 1998 Jul 13; 89(7):733-40. PubMed ID: 9738980
    [Abstract] [Full Text] [Related]

  • 44. Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathway.
    Huang J, Peng K, Wang L, Wen B, Zhou L, Luo T, Su M, Li J, Luo Z.
    Acta Biochim Biophys Sin (Shanghai); 2016 Aug 13; 48(8):750-5. PubMed ID: 27177748
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
    Lv Q, Rong N, Liu LJ, Xu XL, Liu JT, Jin FX, Wang CM.
    Planta Med; 2016 May 13; 82(8):705-11. PubMed ID: 27163230
    [Abstract] [Full Text] [Related]

  • 47. Sodium phenylacetate induces growth inhibition and Bcl-2 down-regulation and apoptosis in MCF7ras cells in vitro and in nude mice.
    Adam L, Crépin M, Savin C, Israël L.
    Cancer Res; 1995 Nov 15; 55(22):5156-60. PubMed ID: 7585564
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Knockdown of p62/sequestosome enhances ginsenoside Rh2-induced apoptosis in cervical cancer HeLa cells with no effect on autophagy.
    Bian S, Zhao Y, Li F, Lu S, Yang S, Liu M, Wang S, Zhao D, Zhang W, Wang J.
    Biosci Biotechnol Biochem; 2021 Apr 24; 85(5):1097-1103. PubMed ID: 33784737
    [Abstract] [Full Text] [Related]

  • 51. Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt.
    Park EK, Lee EJ, Lee SH, Koo KH, Sung JY, Hwang EH, Park JH, Kim CW, Jeong KC, Park BK, Kim YN.
    Br J Pharmacol; 2010 Jul 24; 160(5):1212-23. PubMed ID: 20590613
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways.
    Park HM, Kim SJ, Kim JS, Kang HS.
    Food Chem Toxicol; 2012 Aug 24; 50(8):2736-41. PubMed ID: 22634290
    [Abstract] [Full Text] [Related]

  • 54. Ginsenoside Rh2 Mitigates Pediatric Leukemia Through Suppression of Bcl-2 in Leukemia Cells.
    Wang X, Wang Y.
    Cell Physiol Biochem; 2015 Aug 24; 37(2):641-50. PubMed ID: 26344648
    [Abstract] [Full Text] [Related]

  • 55. Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
    Hou JG, Jeon BM, Yun YJ, Cui CH, Kim SC.
    Int J Mol Sci; 2019 Mar 12; 20(5):. PubMed ID: 30871042
    [Abstract] [Full Text] [Related]

  • 56. Ginsenoside Rh2 inhibits breast cancer cell growth via ERβ-TNFα pathway.
    Peng K, Luo T, Li J, Huang J, Dong Z, Liu J, Pi C, Zou Z, Gu Q, Liu O, Zhang JT, Luo ZY.
    Acta Biochim Biophys Sin (Shanghai); 2022 May 25; 54(5):647-656. PubMed ID: 35593465
    [Abstract] [Full Text] [Related]

  • 57. Sulfated derivatives of 20(S)-ginsenoside Rh2 and their inhibitory effects on LPS-induced inflammatory cytokines and mediators.
    Fu BD, Bi WY, He CL, Zhu W, Shen HQ, Yi PF, Wang L, Wang DC, Wei XB.
    Fitoterapia; 2013 Jan 25; 84():303-7. PubMed ID: 23266729
    [Abstract] [Full Text] [Related]

  • 58. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis.
    Gao H, Liang D, Li C, Xu G, Jiang M, Li H, Yin J, Song Y.
    Biomed Pharmacother; 2020 Apr 25; 124():109891. PubMed ID: 31991384
    [Abstract] [Full Text] [Related]

  • 59. Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism.
    Ma J, Gao G, Lu H, Fang D, Li L, Wei G, Chen A, Yang Y, Zhang H, Huo J.
    Exp Ther Med; 2019 Jul 25; 18(1):630-636. PubMed ID: 31258699
    [Abstract] [Full Text] [Related]

  • 60. Membrane cholesterol delays cellular apoptosis induced by ginsenoside Rh2, a steroid saponin.
    Verstraeten SL, Albert M, Paquot A, Muccioli GG, Tyteca D, Mingeot-Leclercq MP.
    Toxicol Appl Pharmacol; 2018 Aug 01; 352():59-67. PubMed ID: 29782965
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.